pillbase.ru

Вабисмо®

Active substance: faricimab

раствор для внутриглазного введения, 120 мг/мл, 0.24 мл (original in Russian, GRLS)

RussiaActive

Marketing holder: Ф. Хоффманн-Ля Рош Лтд.

Verified 2026-10-09 · GRLS (Russian state register)

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • VABYSMO
    INJECTION, SOLUTION · FARICIMAB 6 mg/.05mL
    50242-096
    Genentech, Inc.
EU 1
  • Vabysmo
    Faricimab
    EMEA/H/C/005642
    Roche Registration GmbH
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-4174-7f9d-b57e-19cf287a1a1f;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-6ac3-7ac6-9c6e-3522ea3a42e5;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
ЛП-№(001664)-(РГ-RU)
Registration status
Active
Dispensing
Prescription only
Release forms
раствор для внутриглазного введения, 120 мг/мл, 0.24 мл - флаконы - пачки картонные /в комплекте с иглой с фильтром/ - По рецепту; (original in Russian, GRLS)
Sources
  • product · GRLS (Russian state register) · ЛП-№(001664)-(РГ-RU) · Verified 2026-10-09
  • registration_status · GRLS (Russian state register) · ЛП-№(001664)-(РГ-RU) · Verified 2026-10-09
  • ingredients.0 · GRLS (Russian state register) · ЛП-№(001664)-(РГ-RU) · Verified 2026-10-09